| 21-06-25 | NattoPharma ASA : - Delisting | AQ |
| 21-06-15 | NattoPharma : Received application for delisting | AQ |
| 21-06-14 | NattoPharma : Annual General Meeting in NattoPharma ASA | AQ |
| 21-06-10 | NattoPharma : OSLO BØRS - SUSPENDED | AQ |
| 21-06-09 | NattoPharma ASA: Compagnie des Levures Lesaffre announces compulsory acquisition | AQ |
| 1 day | +2.35% |
| Manager | Title | Age | Since |
|---|---|---|---|
Kjetil Ramsøy
CEO | Chief Executive Officer | 54 | 2018-02-07 |
Robert Schrama
DFI | Director of Finance/CFO | - | 2020-03-08 |
Gunilla Traberg
PRN | Corporate Officer/Principal | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Frode Marc Bohan
CHM | Chairman | 58 | 2004-11-03 |
| Director/Board Member | 52 | 2011-01-31 | |
Kjetil Ramsøy
BRD | Director/Board Member | 54 | 2015-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.35% | +1.46% | - | - | 86.2M | |
| -1.21% | -5.37% | +39.94% | +145.38% | 992B | |
| -2.48% | -4.17% | +51.52% | +39.07% | 564B | |
| -2.14% | -3.68% | +16.71% | +56.15% | 391B | |
| -1.18% | +0.25% | +25.86% | +16.53% | 330B | |
| -2.36% | -3.12% | +24.71% | +11.59% | 280B | |
| -2.45% | -2.88% | +24.29% | +30.06% | 279B | |
| -1.91% | -0.87% | -41.95% | -49.25% | 196B | |
| -1.19% | -4.65% | +16.56% | +47.00% | 184B | |
| -1.35% | -1.68% | +14.59% | +56.94% | 156B | |
| Average | -1.39% | -1.98% | +19.14% | +39.27% | 374.58B | |
| Weighted average by Cap. | -1.77% | -2.88% | +28.03% | +63.21% |
Employees
18
Sector
Pharmaceuticals
